Trademark: 97149201
Status Date
Tuesday, April 2, 2024
Filing Date
Tuesday, November 30, 2021
Published for Opposition
Tuesday, October 18, 2022
42 Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Apr 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2024
Sou Extension 3 Granted
Apr 2, 2024
Sou Extension 3 Filed
Apr 2, 2024
Sou Teas Extension Received
Oct 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 24, 2023
Sou Extension 2 Granted
Oct 24, 2023
Sou Extension 2 Filed
Oct 24, 2023
Sou Teas Extension Received
Apr 17, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 17, 2023
Teas Change Of Correspondence Received
Apr 17, 2023
Teas Change Of Owner Address Received
Apr 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2023
Sou Extension 1 Granted
Apr 5, 2023
Sou Extension 1 Filed
Apr 5, 2023
Sou Teas Extension Received
Dec 13, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 18, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2022
Published For Opposition
Sep 28, 2022
Notification Of Notice Of Publication E-Mailed
Sep 12, 2022
Approved For Pub - Principal Register
Sep 7, 2022
Assigned To Examiner
Dec 4, 2021
New Application Office Supplied Data Entered
Dec 3, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
